These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 37483692)

  • 1. Effects of different levodopa doses on blood pressure in older patients with early and middle stages of Parkinson's disease.
    Su D; Zhang X; Su Y; Chan P; Xu E
    Heliyon; 2023 Jul; 9(7):e17876. PubMed ID: 37483692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and reaction to dopaminergic treatment of drug-naïve patients with Parkinson's disease in central China: A cross sectional study.
    Zeng W; Wang Y; Liu L; Wu Y; Xu Y; Zhai H; Yang X; Cao X; Xu Y
    Heliyon; 2023 Jul; 9(7):e18081. PubMed ID: 37483764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D deficiency and genetic polymorphisms of vitamin D-associated genes in Parkinson's disease.
    Pal R; Choudhury S; Kumar H; Dey S; Das N; Basu BR
    Eur J Neurosci; 2023 Sep; 58(5):3362-3377. PubMed ID: 37485791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world considerations regarding the use of the combination of levodopa, carbidopa, and entacapone (Stalevo
    Reichmann H
    Eur J Neurol; 2023 Nov; 30 Suppl 2():15-20. PubMed ID: 37489705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromelanin related ultra-high field signal intensity of the locus coeruleus differs between Parkinson's disease and controls.
    Wolters AF; Heijmans M; Priovoulos N; Jacobs HIL; Postma AA; Temel Y; Kuijf ML; Michielse S
    Neuroimage Clin; 2023; 39():103479. PubMed ID: 37494758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tools and criteria to select patients with advanced Parkinson's disease for device-aided therapies: a narrative review.
    Moes HR; Henriksen T; Sławek J; Phokaewvarangkul O; Buskens E; van Laar T
    J Neural Transm (Vienna); 2023 Nov; 130(11):1359-1377. PubMed ID: 37500937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized Integrated Care Promoting Quality of Life for Older People: Protocol for a Multicenter Randomized Controlled Trial.
    Judica E; Tropea P; Bouça-Machado R; Marín M; Calarota E; Cozma L; Badea R; Ahmed M; Brach M; Ferreira JJ; Corbo M
    JMIR Res Protoc; 2023 Jul; 12():e47916. PubMed ID: 37486732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catechol-O-methyltransferase inhibition with entacapone: Evidence from controlled clinical trials in Parkinson's disease.
    Poewe W
    Eur J Neurol; 2023 Nov; 30 Suppl 2():9-14. PubMed ID: 37493495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BDNF/TrkB pathway activation in D1 receptor-expressing striatal projection neurons plays a protective role against L-DOPA-induced dyskinesia.
    Pelosi A; Nakamura Y; Girault JA; Hervé D
    Neurobiol Dis; 2023 Sep; 185():106238. PubMed ID: 37495178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing a framework for quality of inpatient care for Parkinson's disease: A study on inpatient medication administration.
    Yu JRT; Sonneborn C; Hogue O; Ghosh D; Brooks A; Liao J; Fernandez HH; Shaffer S; Sperling SA; Walter BL
    Parkinsonism Relat Disord; 2023 Aug; 113():105491. PubMed ID: 37495500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine agonists in Parkinson's disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment.
    Isaacson SH; Hauser RA; Pahwa R; Gray D; Duvvuri S
    Clin Park Relat Disord; 2023; 9():100212. PubMed ID: 37497384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stalevo
    Jenner P
    Eur J Neurol; 2023 Nov; 30 Suppl 2():3-8. PubMed ID: 37500177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-session transcutaneous auricular vagus nerve stimulation for Parkinson's disease: evaluating feasibility, safety, and preliminary efficacy.
    Lench DH; Turner TH; McLeod C; Boger HA; Lovera L; Heidelberg L; Elm J; Phan A; Badran BW; Hinson VK
    Front Neurol; 2023; 14():1210103. PubMed ID: 37554394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac 18F-Dopamine Positron Emission Tomography Predicts the Type of Phenoconversion of Pure Autonomic Failure.
    Lenka A; Isonaka R; Holmes C; Goldstein DS
    Res Sq; 2023 Jul; ():. PubMed ID: 37503103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review on Natural Antioxidants for Their Role in the Treatment of Parkinson's Disease.
    Mittal P; Dhankhar S; Chauhan S; Garg N; Bhattacharya T; Ali M; Chaudhary AA; Rudayni HA; Al-Zharani M; Ahmad W; Khan SU; Singh TG; Mujwar S
    Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Externally validated deep learning model to identify prodromal Parkinson's disease from electrocardiogram.
    Karabayir I; Gunturkun F; Butler L; Goldman SM; Kamaleswaran R; Davis RL; Colletta K; Chinthala L; Jefferies JL; Bobay K; Ross GW; Petrovitch H; Masaki K; Tanner CM; Akbilgic O
    Sci Rep; 2023 Jul; 13(1):12290. PubMed ID: 37516770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of time to ON versus wearing OFF in total daily OFF time experienced by patients with Parkinson's disease.
    Isaacson SH; Kremens D; Torres-Yaghi Y; Stocchi F; Antonini A
    Parkinsonism Relat Disord; 2023 Sep; 114():105495. PubMed ID: 37517986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Nocturnal Symptoms in Chinese Parkinson's Disease Patients Based on the PDSS-2 Scale: A Multicenter Cross-Sectional Study.
    Su W; Huang P; Ma X; Shang H; Ye Q; Cheng O; Chan P; Liu C; Liu W; Tang B; Wang L; Zhang B; Wang T; Shao M; Xie A; Chen X; Zhu X; Wang J; Tao E; Chen S; Chen H
    J Parkinsons Dis; 2023; 13(6):1061-1071. PubMed ID: 37522220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Neuropsychiatric Symptom Profiles With Cognitive Decline in Patients With Parkinson Disease and Mild Cognitive Impairment.
    Lee YG; Park M; Jeong SH; Baik K; Kang S; Yoon SH; Na HK; Sohn YH; Lee PH
    Neurology; 2023 Sep; 101(12):e1186-e1195. PubMed ID: 37524535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinson's Disease.
    van Wamelen DJ; Leta V; Chaudhuri KR; Jenner P
    Curr Neuropharmacol; 2024; 22(10):1606-1620. PubMed ID: 37526188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.